drugset / Trial / NCT06948357

Efficacy and Safety of BRIMOCHOL PF and CARBACHOL PF in Chinese Presbyopia Patients

NCT06948357

RandomizedCrossoverQuadruple-blindTreatment

Summary

A multicenter, randomized, double-Blind, crossover, placebo-controlled Phase II clinical Study to evaluate the efficacy and safety of BRIMOCHOL PF and CARBACHOL PF in the treatment of Chinese patients with presbyopia.

Timeline

Start
2025-03-24
Primary completion
2025-09-30
Completion
2025-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject BRIMOCHOL Unknown Other
Subject Brimonidine Small molecule Other
Subject CARBAMOYLCHOLINE Small molecule Other

Indications